Pfizer Signs Deal To Boost Supply Of Gilead's Remdesivir For COVID-19 Patients

RTTNews

07 Aug 2020 0 shares 1 views

Pfizer Signs Deal To Boost Supply Of Gilead's Remdesivir For COVID-19 Patients

RTTNews

Published 07 Aug 2020

Pfizer said Friday it reached a multi-year deal with Gilead Sciences to manufacture and supply Gilead's investigational antiviral remdesivir for COVID-19 patients.

Full Article

Kansas plant will produce Covid-19 drug that is in short supply

A Kansas manufacturing plant will help fill demand for remdesivir, a key drug used to treat Covid-19 patients. Pfizer Inc. said..

bizjournals 10 Aug 2020

Under pressure to boost production of Covid-19 drug remdesivir, Gilead inks pact with Pfizer

Gilead Sciences Inc. lashed out earlier this week at state attorneys general critical of the drug maker's production of the..

bizjournals 07 Aug 2020

Pfizer Signs Deal To Boost Supply Of Gilead's Remdesivir For COVID-19 Patients

Pfizer Signs Deal To Boost Supply Of Gilead's Remdesivir For COVID-19 Patients

You might like

Related news coverage

Kansas plant will produce Covid-19 drug that is in short supply

Under pressure to boost production of Covid-19 drug remdesivir, Gilead inks pact with Pfizer

Advertisement